Open access · CC-BY
via OpenAlex
Nicotinamide Riboside Attenuates Cisplatin-Induced Hepatorenal Toxicity Through Restoration of NAD+ Homeostasis and Nrf2/NQO1-Dependent Antioxidant Signaling
Waleed Khaled Younis Albahadly, Mohammed Ibrahim Rasool, Haider Falih Shamikh Al-Saedi, Zahraa Abed Al-Kareem, Samer A. Hasan, Mohammed Abdulaali Sahib, Meeqaat H. Altrufi
Cells · 2026 · ▲ 1 citations
Abstract
Background: Cisplatin is a widely used chemotherapeutic agent whose clinical application is often limited by severe hepatorenal toxicity associated with oxidative stress and cellular injury. Nicotinamide riboside (NR), a natural precursor of nicotinamide adenine dinucleotide (NAD+), has emerged as a promising cytoprotective compound with antioxidant and metabolic regulatory properties. This study investigated the protective effects of NR against cisplatin-induced hepatorenal toxicity and explored its potential mechanisms of action. Methods: Thirty-six adult male Wistar rats were randomly assigned to four groups (n = 6): control, cisplatin (7 mg/kg, i.p.), nicotinamide riboside (50 mg/kg/day, orally), and cisplatin plus NR. Renal and hepatic function biomarkers, lipid profile parameters, oxidative stress markers, and antioxidant status were evaluated. Relative mRNA expression of Nrf2 and NQO1 was determined using RT-qPCR. Histopathological examinations of liver and kidney tissues were also performed. Results: Cisplatin administration induced marked hepatorenal injury, evidenced by significant elevations in serum KIM-1 (395.27 vs. 116.04 ng/mL), urea (71.16 vs. 21.33 mg/dL), creatinine (3.49 vs. 0.26 mg/dL), AST (325.83 vs. 95.16 U/L), and ALT (102.83 vs. 45.50 U/L), accompanied by dyslipidemia, oxidative stress, and severe histopathological alterations. NR treatment significantly attenuated these changes, reducing KIM-1, urea, creatinine, AST, and ALT by 55.5%, 47.8%, 48.1%, 55.4%, and 33.5%, respectively, compared with the cisplatin group. NR also improved antioxidant status by increasing GSH and SOD levels while reducing MDA and NO concentrations. Hepatic NAD+ levels and the NAD+/NADH ratio were significantly decreased by cisplatin and significantly restored by NR treatment. In addition, NR significantly upregulated the relative mRNA expression of Nrf2 and NQO1 and markedly preserved hepatic and renal histological architecture. Pharmacological inhibition of Nrf2 with ML385 significantly attenuated these protective effects of NR across biochemical, lipid, and oxidative stress parameters, confirming that they are, at least in part, Nrf2-dependent. Conclusions: Nicotinamide riboside exerts protective effects against cisplatin-induced hepatorenal toxicity that are mechanistically linked to activation of the Nrf2/NQO1 antioxidant pathway and restoration of hepatic NAD+ homeostasis. This finding supports the potential of NR as an adjunctive strategy for mitigating cisplatin-associated hepatorenal injury and warrants further preclinical and clinical investigation.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/cells15161436
- Canonical
- link ↗
- Fetched
- 2026-11-07 MST
Cite this
APA
Albahadly, W.K.Y., Rasool, M.I., Al-Saedi, H.F.S., Al-Kareem, Z.A., Hasan, S.A., Sahib, M.A., & Altrufi, M.H. (2026). Nicotinamide Riboside Attenuates Cisplatin-Induced Hepatorenal Toxicity Through Restoration of NAD+ Homeostasis and Nrf2/NQO1-Dependent Antioxidant Signaling. <em>Cells</em>. https://doi.org/10.3390/cells15161436
Vancouver
Albahadly WKY, Rasool MI, Al-Saedi HFS, Al-Kareem ZA, Hasan SA, Sahib MA, et al. Nicotinamide Riboside Attenuates Cisplatin-Induced Hepatorenal Toxicity Through Restoration of NAD+ Homeostasis and Nrf2/NQO1-Dependent Antioxidant Signaling. Cells. 2026. doi:10.3390/cells15161436.
BibTeX
@article{waleed2026Nicoti,
title = {Nicotinamide Riboside Attenuates Cisplatin-Induced Hepatorenal Toxicity Through Restoration of NAD+ Homeostasis and Nrf2/NQO1-Dependent Antioxidant Signaling},
author = {Waleed Khaled Younis Albahadly and Mohammed Ibrahim Rasool and Haider Falih Shamikh Al-Saedi and Zahraa Abed Al-Kareem and Samer A. Hasan and Mohammed Abdulaali Sahib and Meeqaat H. Altrufi},
journal = {Cells},
year = {2026},
doi = {10.3390/cells15161436},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
BioMed Research International 2016
Open access · CC-BY
New Therapeutic Concept of NAD Redox Balance for Cisplatin Nephrotoxicity
Redox Biology 2018
Open access · CC-BY
Nicotinamide riboside attenuates alcohol induced liver injuries via activation of SirT1/PGC-1α/mitochondrial biosynthesis pathway
Nutrients 2022
Open access · CC-BY
Supplementation with NAD+ and Its Precursors to Prevent Cognitive Decline across Disease Contexts
Antioxidants 2024
Open access · CC-BY
Nicotinamide Mononucleotide Restores NAD+ Levels to Alleviate LPS-Induced Inflammation via the TLR4/NF-κB/MAPK Signaling Pathway in Mice Granulosa Cells
Antioxidants 2025
Open access · CC-BY
Protective Role of Spermidine Against Diabetes-Induced Ovarian and Endometrial Injury via LC3 and Beclin-1 Modulation
Antioxidants 2024
Open access · CC-BY